{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T14:56:59Z","timestamp":1774709819522,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008091","name":"University of Rochester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007268","name":"Washington University in Saint Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.humpath.2022.06.007","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T11:09:02Z","timestamp":1654945742000},"page":"86-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["NR4A3 fluorescence in situ hybridization analysis in cytologic and surgical specimens of acinic cell carcinoma"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0224-3167","authenticated-orcid":false,"given":"Qiuying","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Bsirini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen J.","family":"Giampoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly R.","family":"Magliocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongren","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.06.007_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1658-3876(09)50035-0","article-title":"Acinic cell carcinoma of the salivary glands: a literature review","volume":"2","author":"Al-Zaher 1","year":"2009","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.humpath.2022.06.007_bib2","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1007\/s00405-015-3855-7","article-title":"Salivary acinic cell carcinoma: reappraisal and update","volume":"273","author":"Poorten","year":"2016","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"key":"10.1016\/j.humpath.2022.06.007_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/cncy.22338","article-title":"Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma","volume":"129","author":"Skaugen","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.humpath.2022.06.007_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12105-020-01213-4","article-title":"NR4A3 immunohistochemistry reliably discriminates acinic cell carcinoma from mimics. Head neck pathol","volume":"15","author":"Wong","year":"2021","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2022.06.007_bib5","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/PAS.0000000000001279","article-title":"Nuclear NR4A3 immunostaining is a specific and sensitive novel marker for acinic cell carcinoma of the salivary glands","volume":"43","author":"Haller","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.007_bib6","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/modpathol.2015.64","article-title":"Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study","volume":"28","author":"Stevens","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.06.007_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4132\/jptm.2018.10.12","article-title":"PLAG1, SOX10, and Myb expression in benign and malignant salivary gland neoplasms","volume":"53","author":"Lee","year":"2019","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.humpath.2022.06.007_bib8","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1158\/1078-0432.CCR-10-0463","article-title":"Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: incidence, variability, and clinicopathologic significance","volume":"16","author":"Mitani","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2022.06.007_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/PAS.0b013e3182002777","article-title":"MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation","volume":"35","author":"West","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.007_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1525-1578(10)60511-9","article-title":"A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands","volume":"6","author":"Martins","year":"2004","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2022.06.007_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ng1083","article-title":"t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway","volume":"33","author":"Tonon","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2022.06.007_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/PAS.0000000000000088","article-title":"Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, beta-catenin, EGFR, and CCND1 genes","volume":"38","author":"Sk\u00e1lov\u00e1","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.007_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","article-title":"Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity","volume":"34","author":"Sk\u00e1lov\u00e1","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.007_bib14","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/cncr.29890","article-title":"Genetic alterations in salivary gland cancers","volume":"122","author":"Yin","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2022.06.007_bib15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41467-018-08069-x","article-title":"Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands","volume":"10","author":"Haller","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2022.06.007_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/1742-6413.162774","article-title":"Is DOG1 really useful in the diagnosis of salivary gland acinic cell carcinoma? - a DOG1 (clone K9) analysis in fine needle aspiration cell blocks and the review of the literature","volume":"12","author":"Canberk","year":"2015","journal-title":"Cytojournal"},{"key":"10.1016\/j.humpath.2022.06.007_bib17","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.prp.2016.08.005","article-title":"High grade transformation of salivary gland acinic cell carcinoma with emphasis on histological diagnosis and clinical implications","volume":"212","author":"Bury","year":"2016","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2022.06.007_bib18","first-page":"1","article-title":"The NR4A subgroup: immediate early response genes with pleiotropic physiological roles","volume":"4","author":"Maxwell","year":"2005","journal-title":"Nucl Recept Signal"},{"key":"10.1016\/j.humpath.2022.06.007_bib19","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cancergen.2014.06.024","article-title":"Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion","volume":"207","author":"Broehm","year":"2014","journal-title":"Cancer Genet"},{"key":"10.1016\/j.humpath.2022.06.007_bib20","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s13277-012-0415-2","article-title":"Identification of genes regulated by the EWS\/NR4A3 fusion protein in extraskeletal myxoid chondrosarcoma","volume":"33","author":"Filion","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/j.humpath.2022.06.007_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cell.2014.02.019","article-title":"A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia","volume":"157","author":"Groschel","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2022.06.007_bib22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ccr.2014.02.008","article-title":"A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression","volume":"25","author":"Yamazaki","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2022.06.007_bib23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/gcc.2870090408","article-title":"Breakpoints of Burkitt's lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC","volume":"9","author":"Zeidler","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2022.06.007_bib24","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.3390\/cancers12092433","article-title":"Oncogenic orphan nuclear receptor NR4A3 interacts and cooperates with MYB in acinic cell carcinoma","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2022.06.007_bib25","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/PAS.0000000000001494","article-title":"Nuclear NR4A2 (Nurr1) immunostaining is a novel marker for acinic cell carcinoma of the salivary glands lacking the classic NR4A3 (NOR-1) upregulation","volume":"44","author":"Haller","year":"2020","journal-title":"Am J Surg Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722001526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722001526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:40:28Z","timestamp":1758645628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722001526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":25,"alternative-id":["S0046817722001526"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.06.007","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NR4A3 fluorescence in situ hybridization analysis in cytologic and surgical specimens of acinic cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}